These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33163583)

  • 1. Management of fast breathing pneumonia in young infants aged 7 to 59 days by community level health workers: protocol for a multi-centre cluster randomized controlled trial.
    ; Mothabbir G; Rana S; Baqui AH; Ahmed S; Ahmed AN; Taneja S; Mundra S; Bhandari N; Dalpath S; Tigabu Z; Andargie G; Teklu A; Tazebew A; Alemu K; Awoke T; Gebeyehu A; Jenda G; Nsona H; Mathanga D; Nisar YB; Bahl R; Sadruddin S; Muhe L; Moschovis P; Aboubaker S; Qazi S
    Int J Clin Trials; 2020; 7(2):83-93. PubMed ID: 33163583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community case management of chest indrawing pneumonia in children aged 2 to 59 months by community health workers: study protocol for a multi-country cluster randomized open label non-inferiority trial.
    Enhanced Management of Pneumonia in Community (EMPIC) Study Group
    Int J Clin Trials; 2020; 7(2):131-141. PubMed ID: 32832583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based amoxicillin treatment for fast breathing pneumonia in young infants 7-59 days old: a cluster randomised trial in rural Bangladesh, Ethiopia, India and Malawi.
    ; Nisar YB
    BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34417274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal place of treatment for young infants aged less than two months with any low-mortality-risk sign of possible serious bacterial infection: Study Protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04055. PubMed ID: 37449353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long should young infants less than two months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalised for? Study protocol for a randomised controlled trial from low- and middle-income countries.
    PSBI Study Group
    J Glob Health; 2023 Jul; 13():04056. PubMed ID: 37448340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
    Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
    J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1758-1766. PubMed ID: 25842223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial.
    AFRIcan NEonatal Sepsis Trial Group
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S33-8. PubMed ID: 23945574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.
    Tikmani SS; Muhammad AA; Shafiq Y; Shah S; Kumar N; Ahmed I; Azam I; Pasha O; Zaidi AK
    Clin Infect Dis; 2017 Jan; 64(2):184-189. PubMed ID: 27941119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated community case management of childhood illness in low- and middle-income countries.
    Oliphant NP; Manda S; Daniels K; Odendaal WA; Besada D; Kinney M; White Johansson E; Doherty T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012882. PubMed ID: 33565123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions.
    Berhane M; Girma T; Tesfaye W; Jibat N; Abera M; Abrahim S; Aboubaker S; Nisar YB; Ahmad Qazi S; Bahl R; Abdissa A
    PLoS One; 2021; 16(8):e0255210. PubMed ID: 34370744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mobile health-enhanced supportive supervision and supply chain management on appropriate integrated community case management of malaria, diarrhoea, and pneumonia in children 2-59 months: A cluster randomised trial in Eastern Province, Zambia.
    Biemba G; Chiluba B; Yeboah-Antwi K; Silavwe V; Lunze K; Mwale RK; Hamer DH; MacLeod WB
    J Glob Health; 2020 Jun; 10(1):010425. PubMed ID: 32509293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research.
    Leul A; Hailu T; Abraham L; Bayray A; Terefe W; Godefay H; Fantaye M; Qazi SA; Aboubaker S; Nisar YB; Bahl R; Tekle E; Mulugeta A
    PLoS One; 2021; 16(2):e0244192. PubMed ID: 33544712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
    Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA
    Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulse oximeter with integrated management of childhood illness for diagnosis of severe childhood pneumonia at rural health institutions in Southern Ethiopia: results from a cluster-randomised controlled trial.
    Tesfaye SH; Gebeyehu Y; Loha E; Johansson KA; Lindtjørn B
    BMJ Open; 2020 Jun; 10(6):e036814. PubMed ID: 32565474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
    Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
    BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria.
    Ayede AI; Ashubu OO; Fowobaje KR; Aboubaker S; Nisar YB; Qazi SA; Bahl R; Falade AG
    PLoS One; 2021; 16(3):e0248720. PubMed ID: 33784321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.